Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(38): 1907-1910
DOI: 10.1055/s-0028-1085575
DOI: 10.1055/s-0028-1085575
Aktuelle Diagnositk und Therapie
Hepatologie© Georg Thieme Verlag KG Stuttgart · New York
Das hepatozelluläre Karzinom
Hepatocellular carcinoma – diagnosis and treatmentFurther Information
Publication History
eingereicht: 29.4.2008
akzeptiert: 10.7.2008
Publication Date:
10 September 2008 (online)

Schlüsselwörter
hepatozellulläres Karzinom - Leberzirrhose - Radiofrequenzablation - transarterielle Chemoembolisation
Key words
hepatocellular carcinoma - liver cirrhosis - radiofrequency ablation - transarterial chemoembolisation
Literatur
- 1
Bruix J, Sherman M.
Management of hepatocellular
carcinoma.
Hepatology.
2005;
42
1208-1236
MissingFormLabel
- 2
Fattovich G, Stroffolini T, Zagni I, Donato F.
Hepatocellular carcinoma in
cirrhosis: incidence and risk factors.
Gastroenterology.
2004;
127
S35-50
MissingFormLabel
- 3
Ferlay J, Autier P, Boniol M. et
al .
Estimates of the cancer incidence and mortality
in Europe in 2006.
Ann Oncol.
2007;
18
581-592
MissingFormLabel
- 4
Forner A, Vilana R, Ayuso C. et
al .
Diagnosis of hepatic nodules 20 mm or
smaller in cirrhosis: Prospective validation of the noninvasive
diagnostic criteria for hepatocellular carcinoma.
Hepatology.
2008;
47
97-104
MissingFormLabel
- 5
Garrean S, Hering J, Saied A, Helton W S, Espat N J.
Radiofrequency ablation of primary and metastatic
liver tumors: a critical review of the literature.
Am
J Surg.
2008;
195
508-520
MissingFormLabel
- 6
Greten F R, Papendorf F, Bleck J S. et al .
Survival rate in patients with hepatocellular
carcinoma: a retrospective analysis of 389 patients.
Br
J Cancer.
2005;
92
1862-1868
MissingFormLabel
- 7
Greten T F, Blum H E, Manns M P, Geissler M.
Therapie
des hepatozellulären Karzinoms.
Z Gastroenterol.
2006;
44
43-49
MissingFormLabel
- 8
Greten T F, Wedemeyer H, Manns M P. .
Prävention Virus-assoziierter Karzinomentstehung:
Am Beispiel des hepatozellulären Karzinoms.
Deutsches Ärzteblatt.
2006;
103
A-1817
MissingFormLabel
- 9
Greten T F.
Molecular therapy for HCC?.
Z Gastroenterol.
2006;
44
205-206
MissingFormLabel
- 10
Llovet J M, Burroughs A, Bruix J.
Hepatocellular carcinoma.
Lancet.
2003;
362
1907-1917
MissingFormLabel
- 11
Llovet L, Ricci S, Mazzaferro V. et al .
Sorafenib improves survival in advanced
hepatocellular carcinoma (HCC): Results of a phase III randomized
placebo-controlled trial (SHARP trial).
J Clin Oncol.
2007;
25
962s
MissingFormLabel
- 12
Mazzaferro V, Regalia E, Doci R. et al .
Liver transplantation for the treatment
of small hepatocellular carcinomas in patients with cirrhosis.
N Engl J Med.
1996;
334
693-699
MissingFormLabel
- 13
Talwalkar J A, Gores G J.
Diagnosis and
staging of hepatocellular carcinoma.
Gastroenterology.
2004;
127
S126-132
MissingFormLabel
- 14
Varela M, Real M I, Burrel M. et al .
Chemoembolization of hepatocellular carcinoma
with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
J Hepatol.
2007;
46
474-481
MissingFormLabel
- 15
Williams R, White J, Croce M, Dilawari R.
Surgical options in the
treatment of hepatocellular carcinoma.
Am Surg.
2007;
73
658-662;
discussion 662 – 653
MissingFormLabel
Prof. Dr. Tim F. Greten
Klinik für Gastroenterologie, Hepatologie
und Endokrinologie, Medizinische Hochschule Hannover
Carl Neuberg Str. 1
30625 Hannover
Email: greten.tim@mh-hannover.de